You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
Nine members of the HMO Research Network "will use detailed clinical profiles to search for potential subjects to enroll into … serious adverse events research projects using their electronic medical record databases," iSAEC said in a statement.
The consortium and the network will collaborate to identify genetic traits for adverse drug reactions.
The new partners include the University of Liverpool, Newcastle University, the HMO Research Network, and Cerner.
The SAEC will work with an HMO network to identify genetic variants for adverse reactions to antipsychotic medications.
Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.
A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.
In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.
According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.